Live Chat

AstraZeneca 거래 AZN

매도
 매수

AstraZeneca 실시간 차트

5m 15m 30m 1h 4h 1d 1w

상품 기초

Weekly Search
Weekly
Daily
날짜 종료 변경 변동(%) 열기 높음 낮음

최신 뉴스

Tommy Yap 2025 Mar 15, 16:00

Week Ahead: BoJ, Fed, SNB, and BoE: How Will They Shape the Market?

Forex Indices
Frances Wang 2025 Mar 13, 16:00

Bank of Japan to discuss economic risks associated with the Trump trade war

Fed BoJ
Frances Wang 2025 Mar 13, 16:00

Dow Jones futures decline following a Nasdaq rally led by Tesla and Nvidia

Indices
Tommy Yap 2025 Mar 13, 16:00

Morning Note: UK GDP Data, NVDA Stock Dip, & CAD Weakness Amid Oil Decline

Morning Note NVDA Forex Oil
Frances Wang 2025 Mar 12, 16:00

Stock market today: Dow and S&P 500 Remain Steady over Calm CPI Report

Stocks Indices
Frances Wang 2025 Mar 12, 16:00

XRP price news today: XRP Surpasses Tether

Cryptocurrencies
Tommy Yap 2025 Mar 12, 16:00

Morning Note: U.S. Inflation Eases, S&P 500 Rises, Oil Faces Trade War Fears

Morning Note USD Stocks Commodities Forex
Frances Wang 2025 Mar 11, 16:00

CPI report expectations: How is the current U.S. economy?

Fed

정보

스프레드

76.03

스프레드(%)

0.6353 %

레버리지

1:10

익일 이자 매수

-0.0590 %

익일 이자 매도

-0.0299 %

통화

PNC

거래 시간

시장 폐장

월요일

08:01 - 11:59

화요일

08:01-11:59

화요일

12:03-16:29

수요일

08:01-11:59

수요일

12:03-16:29

목요일

08:01-11:59

목요일

12:03-16:29

금요일

08:01-11:59

금요일

12:03-16:29

분석 및 통계

열기

---

이전 종가

---

52주 최고/최저

--- – ---

시가총액

185926205440

발행 주식 수

1550160000

수익 날짜 (다음)

0000-00-00

배당수익률

배당락일

2025-02-20

예상 연간 배당금

2.46

예상 연간 배당수익률

0.0205

EPS

3.48

이 상품에 대해 자세히 알아보기

AstraZeneca AstraZeneca PLC
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, Byetta, XIGDUO, Accolate, Accoleit, Vanticon, Beyfortus, Synagis, FluMist, tixagevimab and cilgavimab, and sipavibart. It also provides Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Bricanyl Turbuhaler, Rhinocort, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Breztri Aerosphere, Duaklir Genuair, Kavigale, Evusheld, Fluenz/FluMist, and Voydeya. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the United States, Europe, and Asia. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

관련 상품

자산
매도
매수
변동(%)

지금 거래하기

지금 거래하기

지금 거래하기

지금 거래하기
view_all_instruments
Trustpilot
Live Chat